Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Matti Annala

机构：Tampere University · ORCID：0000-0001-8478-9026

发表论文 467 篇 · 总被引 17240 次 · h-index 45

代表论文

  • Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancer (2026 · Nature Communications · 被引 1)
  • Abstract 5107: Feasibility and interim results from the prospective international LS-URO study: Urine tumor DNA-based screening for urothelial cancer in Lynch syndrome carriers (2026 · Cancer Research)
  • Figure 2 from NOUS-209 Off-the-shelf Immunotherapy Has the Potential to Hit Primary and Metachronous Colorectal and Urothelial Cancers in Lynch Syndrome (2026)
  • Data from NOUS-209 Off-the-shelf Immunotherapy Has the Potential to Hit Primary and Metachronous Colorectal and Urothelial Cancers in Lynch Syndrome (2026)
  • Figure 4 from NOUS-209 Off-the-shelf Immunotherapy Has the Potential to Hit Primary and Metachronous Colorectal and Urothelial Cancers in Lynch Syndrome (2026)
  • Supplementary Figure S1 from NOUS-209 Off-the-shelf Immunotherapy Has the Potential to Hit Primary and Metachronous Colorectal and Urothelial Cancers in Lynch Syndrome (2026)